baber/WOPTO huggingface dataset:
Patent MD-20070053-A (MD)
Title: Process and device for liquid separation
Inventor: LAPOVŞCIUC Nicolae
IPC: B01D17/038
Filed: 2007-03-01
Abstract: The invention relates to a process and a device for liquid separation, particularly alcohol and water, and can be used in the wine-making industry, or in other branches of industry, where liquid separation is carried out by the distillation and rectification method.The process for liquid separation is carried in gravitational field according to the difference in specific weight of the liquid components.The device for liquid separation represents a centrifuge, consisting of a body (1) with an actuating mechanism, a liquid component removal device (2), wherein there are placed branch pipes (10), equipped with valves (8, 9) and gates (11, 12). The claimed device also comprises a liquid feeding branch pipe (3), equipped with a valve (7) and a gate (6).
Patent MX-154265-A (MX)
Inventor: BREC RAYMOND
IPC: H01M6/14
Filed: 1980-08-28
Abstract: A secondary electric cell which includes: a non-aqueous electrolyte, a negative electrode whose active material includes at least one alkali metal in contact with the electrolyte, and a positive electrode whose active material is suitable for intercalating the active material of the negative electrode, wherein said positive electrode includes an active compound or solid solution whose general formula is MxX, RyX3 where: M is an element chosen from lead and tin; R is an element chosen from bismuth and antimony; and X is an element chosen from sulphur and selenium, with x having a value lying between 0 and 1 (inclusive), and y having a value lying between 0 and 2 (inclusive). Such cells may be used in watches or pacemakers.
Patent MX-160901-A (MX)
Inventor: DIXON THOMAS JEFFERSON
IPC: A61K8/00
Filed: 1982-09-28
Abstract: Skin conditioning compositions are described which comprise an emulsion of a volatile, water-insoluble liquid; glycerin; a polydiorganosiloxane-polyoxyalkylene copolymer; a surfactant which will emulsify the above named water-insoluble components; and water.
Patent NZ-191150-A (NZ)
Title: Papermaking fabric with five-shed weaving pattern
Inventor: MCDONALD R
IPC: D21F1/10
Filed: 1979-07-27
Abstract: A fabric (10), adapted for use in a belt of a papermaking machine, is formed of interwoven machine direction warp (12) and cross-machine direction shute (14) type strands, at least the shute strands (14) being woven in a repetitive pattern of passing under at least three adjacent warp strands (12) and then passing over at least two adjacent warp strands (12) so as to form a <2>/3 type weave pattern.
Patent NZ-195944-A (NZ)
Title: Hybridoma for producing monoclonal antibody to human monocytes and granulocytes;antibody;therapeutic compositions and diagnostic methods
Inventor: KUNG P C-S
IPC: C12N15/00
Filed: 1981-01-06
Abstract: Hybrid cell line for production of monoclonal antibody to an antigen found on normal human monocytes and granulocytes. The hybrid is formed by fusing splenocytes from immunized BALB/cJ mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.
Patent NZ-214351-A (NZ)
Title: Treating textiles with keratolytic liquid and ceramic glazing powder
Inventor: NORDMANN H
IPC: D06M11/51
Filed: 1985-11-27
Abstract: A process for the treatment of textile materials consisting of or containing natural vegetable or animal fibres, in which (a) ketatolytic liquid is allowed to act on the textile material, and then washed out, then preferably the material is further treated with an oxidizing agent which thereafter is washed out, (b) the textile material is impregnated with a suspension of a finely-divided frit or glazing powder, and (c) the impregnated material is subjected to heat-treatment at a temperature of above 180°C.
Patent NZ-219654-A (NZ)
Title: Human tissue plasminogen activator deglycosylated at position 117 only
Inventor: HOTCHKISS ADAIR JOHN
IPC: C12N15/09
Filed: 1987-03-17
Abstract: Disclosed are various novel human tissue-type plasminogen activators characterised by having a modified carbohydrate structure at amino acid residue 117. Means for their preparation and results of assays measuring function of the activators are also disclosed.
Patent NZ-224679-A (NZ)
Title: Process for producing stereoregular polymers having a narrow molecular weight distribution
Inventor: BRADY ROBERT CONVERSE
IPC: C08F10/00
Filed: 1988-05-18
Abstract: Stereoregular polymers having a molecular weight distribution of less than 5.0 and an isotactic index in excess of 96 percent are produced by polymerizing an alpha-olefin having 3 to 8 carbon atoms in a low pressure gas phase fluid bed process at a temperature in excess of 80 DEG C employing a heat stable catalyst system comprising (a) a solid catalyst component containing magnesium, titanium, halide and a polycarboxylic acid ester containing two coplanar ester groups attached to adjacent carbon atoms, as inside electron donor, (b) an organoaluminum cocatalyst, and (c) a silicon compound containing a silicon-oxygen-carbon linkage, as outside electron donor.
Patent NZ-230111-A (NZ)
Title: Unglycosylated human il-2 produced by recombinant means
Inventor: LANDO DANIELLE
IPC: C07K1/113
Filed: 1989-07-27
Abstract: The invention relates to a nonglycosylated, recombinant human IL2 in which the three cysteines in positions 58, 105 and 125 are in the reduced form and which exhibits a biological activity comparable with that of the oxidised IL2 having the same sequence and containing a disulphide bridge in position 58-105, to the process for obtaining it and to its application as a medication.
Patent NZ-230916-A (NZ)
Title: Peptidase inhibitors and pharmaceutical compositions thereof
Inventor: BEY PHILIPPE
IPC: C07C229/36
Filed: 1989-10-05
Abstract: This invention relates to analogs of peptidase substrates in which the nitrogen atom of the scissile amide group of the substrate peptide has been replaced by a substituted malonyl moiety. The contemplated peptidase inhibitors of the foregoing enzymes are selected from the generic formula <CHEM> the hydrates, isosteres or the pharmaceutically acceptable salts thereof wherein X is <CHEM> R1 is hydrogen, an amino protecting group selected from Group K, an alpha -amino acid or a peptide comprised of a number of  alpha -amino acid building blocks, said  alpha -amino acid or peptide optionally bearing on its terminal nitrogen atom an amino protecting group selected from Group K, R2 is the "R group" residue of the  alpha -amino acid responsible for directing the inhibitor to the active site of the enzyme or is -A-SiR7R8R9, C1-10 alkyl, aralkyl or aryl with R7, R8 and R9, each being selected from C1-10, alkyl, aralkyl or aryl and A is a C1-6 alkylene, R4 is the specific R-group residue of the  alpha -amino acid for that peptidase substrate analog, R5 is an  alpha -amino acid or peptide comprised of  alpha -amino acids or is deleted,  Y is NHR3 or OR3 with R3 being H, C1-7 alkyl, benzyl or phenethyl. These analogs of the peptidase substrates provide specific enzyme inhibitors for a variety of proteases, the inhibition of which will have useful physiological consequences in a variety of disease states.
Patent NZ-234160-A (NZ)
Title: Process for preparing 4,5,6,7-tetrahydro thieno (3,2-c) pyridine derivatives
Inventor: BOUISSET MICHEL
IPC: C07C51/295
Filed: 1990-06-20
Abstract: Compounds of formula    <IMAGE>  I  in which R1 and R2 are hydrogen or halogen, are prepared by reacting an aldehyde of formula: <IMAGE> IV  with CHBr3 and KOH in a mixture of an inert solvent and water. Further an ester of compound (I) wherein R1 is H and R2 is 2-Cl is reacted with 4,5,6,7-tetrahydrothieno[3,2-c]pyridine to produce a compound of formula III:   <IMAGE>  which is useful as a medicament.
Patent NZ-244010-A (NZ)
Title: Process for the production of 6-fluoro-1,2-benzisothiazole derivatives
Inventor: FINK DAVID M
IPC: C07D451/02
Filed: 1992-08-19
Abstract: A process for the preparation of 6-fluoro-1,2-benzisothiazoles of formula I <CHEM> where R is hydrogen, loweralkyl, cycloalkyl, aralkyl, aryl, or a group of the formulae <CHEM> -CO<6>R<6>, -CN or -C(=O)R;<6> R<6> is alkyl or aryl; k, m, m<*>, n and n<*> are independently integers from 1 to 4; which comprises     a) reacting a compound of the formula III <CHEM> wherein R is as defined above and R<7> is hydrogen, loweralkyl, or arylloweralkyl, with a halogenating agent to obtain a compound of the formula IV <CHEM>  wherein R is as defined and Hal is halogen, and b) reacting the compound of formula IV as obtained in step a) with ammonia. s
Patent NZ-245287-A (NZ)
Title: 1-(phenylalkyl-substituted)-benzimidazole derivatives and their use in pharmaceutical compositions
Inventor: AXELSSON OSKAR
IPC: A61P25/28
Filed: 1992-11-26
Abstract: The present invention discloses compounds of the formula <CHEM>  wherein R' and R'' independently of each other are hydrogen or alkyl, or R' and R'' together form a 3 to 6 membered alkylene chain;  n is 1 or 2; R<1> is phenyl which may be substituted one or more times with halogen, CF3, alkoxy, alkyl, or amino; and R<4>, R<5>, R<6> and R<7> independently of each other are hydrogen, halogen, amino, CF3, alkyl or alkoxy; or a pharmaceutically-acceptable addition salt thereof. The compounds are useful as pharmaceuticals, for example, in the treatment of ischemia, anoxia, migraine and psychosis.
Patent NZ-278551-A (NZ)
Title: Ibuprofen particles with improved powder flow properties
Inventor: MOLLER TORSTEN
IPC: A61K47/32
Filed: 1995-01-26
Abstract: PCT No. PCT/AT95/00014 Sec. 371 Date Jul. 12, 1996 Sec. 102(e) Date Jul. 12, 1996 PCT Filed Jan. 26, 1995 PCT Pub. No. WO95/20382 PCT Pub. Date Aug. 3, 1995A process for the production of S(+)-ibuprofen-particles having improved flow properties comprises the steps that coarse-crystalline S(+)-ibuprofen is molten and then in a molten condition is finely distributed in a non-solving medium, preferably in cold water, and is chilled therein. This chilling results in a fine-crystalline primary structure that agglomerates to a secondary structure. In this agglomerate form the product is obtained which is filtered out and is dried. Such particles are suitable for direct pressing of tablets, optionally, tableting auxiliary substances being added, also for the production of tablets having a retarded release of the active substance.
Patent NZ-308657-A (NZ)
Title: Fused polycyclic heterocycle derivatives
Inventor: SUGUMI HIROYUKI
IPC: C07D491/16
Filed: 1996-05-31
Abstract: Novel fused polycyclic heterocycle derivatives having excellent antitumor effects and a process for producing the same. A compound represented by the following general formula (I) or pharmacologically acceptable salts thereof: <CHEM> wherein the ring A represents an optionally substituted monocyclic aromatic ring or a dicyclic fused ring in which at least one of the rings is an aromatic ring; the ring B represents pyrrole, 4H-1,4-oxazine, 4H-1,4-thiazine or 4(1H)-pyridone; the ring C represents an optionally substituted, monocyclic or dicyclic fused aromatic ring; and Y represents a group represented by the formula -e-f (wherein e represents a lower alkylene; and f represents amidino, guanidino or amino optionally substituted by optionally hydroxylated or optionally lower-alkylaminated lower alkyl; provided that the cases where the rings A and B are both optionally substituted monocyclic aromatic rings are excluded. Which has an excellent antitumor activity.
Patent NZ-319825-A (NZ)
Title: process for extracting xanthophyll crystals from a plant extract
Inventor: AUSICH RODNEY L
IPC: C07C35/21
Filed: 1996-09-24
Abstract: The process for extracting xanthophyll crystals from a xanthophyll diester containing plant extract (oleoresin) comprises: a)  admixing the oleoresin with propylene glycol with heating to a temperature to a temperature of 50 to 60oC to form a homogeneous liquid; b) admixing an aqueous alkali solution of sodium or potassium hydroxide with the liquid from step a) to form a saponification reaction mixture that consists essentially of 35 to 50 wt% oleoresin, 30 to 45 wt% propylene glycol, 5 to 10 wt% alkali as sodium or potassium hydroxide and 7 to 15 wt% water as initially admixed components wherein the total weight of the oleoresin and propylene glycol constitutes at least 75 wt% of the reaction mixture; c) maintaining the mixture of step b) at a temperature of 65 to 80oC for a time period to saponify the xanthophyll diester and form a saponified reaction mixture containing xanthophyll crystals; d) admixing 3 to 19 volumes of water at a temperature of 60 to 800C per volume of the mixture of step c) to form a diluted reaction mixture containing xanthophyll crystals; e) gently admixing the diluted reaction mixture until homogeneous; f) collecting the xanthophyll crystals from the diluted mixture of step e) and g) washing and then drying the collected xanthophyll crystals.
Patent NZ-328519-A (NZ)
Title: Barrier and fencing structure designed to stop climbing animals comprising an elevated structure and a climbing barrier
Inventor: FULLER STEPHEN ANDREW
IPC: E04H17/00
Filed: 1997-08-08
Abstract: The specification describes a rigid, non-electrified barrier.  The barrier comprises: An elevated structure (usually a mesh fence) and A barrier extending along the elevated structure. The barrier, which is usually a rigid sheet of plastic or metal, is dimensioned so as to prevent an animal over and beyond the barrier.  The elevated structure is designed to prevent an animal squeezing through or burrowing under it. A preferred option is depicted.
Patent NZ-336645-A (NZ)
Title: Winding optical fibre on to reel after production, initial length led from main bobbin to auxiliary bobbin
Inventor: ROGERSON JOHN WILLIAM
IPC: B65H65/00
Filed: 1999-07-08
Abstract: An optical fibre 16, after being drawn from a preform, is wound around bobbin 12, and then around auxiliary bobbin 14.  Both bobbins are driven, and the tension in the fibre can be controlled by controlling the relative rotational speeds of the bobbins.  The fibre wound on to the bobbin 14 can be tested for quality.  If the quality of the fibre is found to be acceptable, the fibre is cut between the two bobbins and the fibre wound onto bobbin 12.  This arrangement allows the quality of the fibre to be checked while only a small amount of fibre has been produced, reducing fibre wastage.
Patent NZ-502675-A (NZ)
Title: 2-3-[4-(2-t-butyl-6-trifluoromethyl-4-pyrimidinyl)-1-piperazinyl]propylthio-4-pyrimidinol fumarate
Inventor: HOGER THOMAS
IPC: A61P43/00
Filed: 1998-08-14
Abstract: The specification describes the fumaric acid salt (A) of 2-(3-(4-(2-tert.butyl-6-trifluoromethyl- pyrimidin-4-yl)piperazin-1yl)propylmercapto)pyrimidin-4-ol (I).  The fumaric salt of this known compound (WO96/02519) is reported to have very good affinity and high selectivity for the D3 receptor and is therefore useful for treating disorders which respond to dopamine D3 ligands such as schizophrenia, depressions, neuroses and psychoses.
Patent NZ-503085-A (NZ)
Title: Lipophilic diesters of 1,2-bis(2-amino-phenoxy)ethane-N,N,N,N-tetraacetic acid
Inventor: KOZAK ALEXANDER
IPC: A61K31/223
Filed: 1998-09-27
Abstract: A stable di-esterified carboxylic acid with hydroxy compound (b) is a pharmaceutically acceptable chelating agent for divalent metal ions and has the formula  (HOOC-CH2-)2-N-A-N-(-CH2COOH)2 wherein: A is optionally saturated aliphatic, aromatic or heterocyclic linking radical containing, in a direct chain link between the two depicted nitrogen atoms, 2-8 carbon atoms in a continuous chain which may be interrupted by 2-4 oxygen atoms, provided that the chain members directly connected to the two depicted nitrogen atoms are not oxygen atoms, and (b) is a pharmaceutically acceptable alcohol selected from the group of straight chain or branched, saturated or unsaturated alkyl, aminoalkyl and substituted or unsubstituted arylalkyl radicals. The diesters are useful for treating a condition or disease related to an excess of divalent metal ions such as brain or cardiac ischemia, stroke, epilepsy, Alzheimer's disease or cardiac arrhythmia.
Patent NZ-503091-A (NZ)
Title: Wound dressing with an indicator layer changing colour on contact with moisture
Inventor: EAKIN THOMAS GEORGE
IPC: A61L15/56
Filed: 1998-09-01
Abstract: An indicator wound dressing consisting of a covering release layer, a dressing layer, an indicator layer, a transparent or translucent indicator bonding layer and a transparent or translucent outer covering. The indicator layer contains a dye which changes colour on contact with water. When the dressing layer becomes saturated, water permeates the indicator layer and triggers a colour change. The colour change is visible through the indicator bonding layer and outer covering and shows a carer that the dressing needs to be replaced.
Patent NZ-504942-A (NZ)
Title: Phenol foam comprising a fluoroamine-containing phenol resin with pores filled with a C4-6 saturated hydrocarbon gas
Inventor: ARITO YUUICHI
IPC: C08J9/14
Filed: 1998-12-09
Abstract: The phenol resin foam heat-insulating material has a phenol foam with an independent porosity of at least 80%, an average pore size in the range of 10-400 µm, and a thermal conductivity of 0.025 kcal/mhrÚ C or lower.  The phenol foam is composed of a portion of pores filled with a gas containing C4- 6 saturated hydrocarbon and a resin portion made of a phenol resin containing 0.01-5 wt% of at least one type of fluoroamine represented by the formula (CaFb)3N, where a is a natural number of 4 or larger and b is 2a + 1.
Patent NZ-509863-A (NZ)
Title: Trypsin substrate, a diagnostic device, and use in assay for urinary trypsin inhibitor
Inventor: COREY PAUL F
IPC: G01N33/493
Filed: 2001-02-12
Abstract: Compounds of formula (I) are described wherein R1 is a protecting group for Ná, R2 is a protecting group for NG; and R3 is aryl, and wherein the compound of formula (I) is a trypsin substrate such that trypsin cleaves the O-C single bond, which liberates R3-OH. These compounds are used to produce visible colours in dry-phase analytical elements so as to detect quantities of urinary trypsin inhibitor (UTI) in a biological sample such as urine. The compounds of formula (I) provide aromatic esters of Ná (á amino group) and NG (guanidine group) bis-protected arginine that are trypsin substrates.  The trypsin hydrolyses esters of arginine and protecting groups on the guanidine moiety.
Patent NZ-511093-A (NZ)
Title: Crystallization of doxorubicin hydrochloride
Inventor: JOHDO OSAMU
IPC: C07H15/252
Filed: 1999-10-15
Abstract: A method of crystallising doxorubicin hydrochloride from a doxorubicin hydrochloride-containing solution, where the doxorubicin hydrochloride-containing solution is a water-based solution containing a poor solvent to doxorubicin hydrochloride and doxorubicin, and the crystallisation is carried out at a temperature of 40oC or higher. Also described is a crystalline aggregate of doxorubicin hydrochloride characterized in that: i) Moisture content accounts for 2 % by weight or less and the other total residual solvents account for 1.5 % or less. ii) The average particle diameter is 15 mm or more in terms of a circle-corresponding diameter determined by image projection. iii) The aggregate has solubility such that it is substantially completely dissolved in water in 2 minutes or shorter under a stirring condition at 25oC.
Patent NZ-511144-A (NZ)
Title: Low output noise switched mode power supply
Inventor: JAMES DAVID ALUN
IPC: H02M1/12
Filed: 2001-04-12
Abstract: A switched mode power supply includes a dc-to-dc converter with a transformer T1 operable at the converter switching frequency. The transformer includes a primary winding and a secondary winding, a pair of capacitors C1, C2 connected in series between the secondary transformer circuit and the primary transformer circuit, and an inductor connected between the junction of the two capacitors and chassis earth. The capacitance of the capacitors and the inductance of the inductor are selected so that the capacitors in series present a low impedance to noise signals and the inductor presents a high impedance to noise frequencies.
Patent NZ-512711-A (NZ)
Title: Program reproducing method and device, and medium on which a program for program reproduction recording
Inventor: NEGORO FUMIO
IPC: G06F9/44
Filed: 2000-11-10
Abstract: A computer program translation method for translating a computer program into a form consistent with the Lyee development method. The method extracts words from the original program and identifies a definitive of the extracted word. The extracted word is then assigned to a pallet based on the corresponding definitive of that word. The extracted words are then converted to the Lyee development method equivalent belonging to the assigned pallet (which the extracted word belongs to).
Patent NZ-513426-A (NZ)
Title: Antibodies that bind to tumor gene sequences
Inventor: ASHKENAZI AVI J
IPC: C12Q1/68
Filed: 2000-02-11
Abstract: An isolated antibody that binds to PRO5775 polypeptide and induces the death of the cell that expresses the polypeptide. Also disclosed is a method of determining the presence of such a polypeptide and thus the use in diagnosing tumors in mammals. Further is a method of identifying compounds that inhibit the immunological activity if PRO5775.
Patent NZ-513896-A (NZ)
Title: Process for extracting polyphenolic antioxidants from purine-containing plants
Inventor: HOVING HENDRIK DERK
IPC: A23L33/105
Filed: 2000-02-02
Abstract: A process for isolating polyphenolic antioxidants from purine-containing plant material, comprising the steps of:   (a) extracting the plant material with an hydroxylic extracting liquid preferably at low temperature; (b) adsorbing the extract obtained in step (a), preferably at low temperature; (c) desorbing the adsorbed material with a hydroxylic desorbing liquid, preferably at relatively high temperature; and   (d) concentrating and optionally drying the desorbed material.   The process is especially suitable for producing cocoa antioxidants ofr use in pharmaceutical, cosmetic and nutritional compositions.
Patent NZ-515450-A (NZ)
Title: Guided cutting system
Inventor: LIRA-NUNEZ CARMEN
IPC: B26B3/00
Filed: 2000-04-11
Abstract: A guided cutting system including first and second blade cartridges (10, 10') which are used in association with templates (12). The blade cartridges each include a head portion (14) and cover portion (16) wherein the head portion includes a non-use end and a cutting end. The cutting end includes a pair of guide pegs (24, 26) and a cutting blade (32) wherein the guide pegs are adapted to be received within a peripheral groove (84) formed on a template. The cover portion is adapted to be attached to the non-use end of the head portion whereby the cover portion acts as a handle for guiding the head portion during a cutting operation. Alternatively, the head portion may be attached over the cutting end of the head portion to cover and prevent contact with the cutting blade. A different spacing is provided between the cutting blade and guide pegs for the first and second head portions whereby one head portion may be used for cropping a photograph and the other head portion may be used for cutting a corresponding backing mat for the photograph.
Patent NZ-516809-A (NZ)
Title: Recombinant tick-derived protease inhibitor proteins
Inventor: NUTTALL PATRICIA ANNE
IPC: A61P11/00
Filed: 2000-07-19
Abstract: The specification relates to a recombinant protein that functions as an inhibitor of tryptase and exhibits significant sequence homology with the tick-derived protease inhibitor protein (TdPI). It also claims an active fragment of the above recombinant protein where the sequence homology is defined as 50% or more of the amino acids in the sequence as completely conserved to the recombinant protein when aligned. This recombinant protein can be used in a pharmaceutical composition with an appropriate carrier or alternatively as a vaccine.